Russia’s Covid -19 vaccine to be foreseen as ‘the bright end of a tunnel’
Amidst this panicogenic situation of increasing corona virus cases, Russia has come up avowedly with Russia’s first Covid-19 vaccine. The vaccine jointly developed by the Gamaleya Research Institute and the Russian Defense Ministry is currently expected to be registered on August 12.
After completion of the third stage trial of the vaccine, hopefully it would be available to the general public by mid september.
The trials have reportedly turned positive for the corona positive people and are said to have developed immunity against the contagious virus.
Taking into concern the severity of the present situation, the World Health Organization (WHO) has emphasized that before launching any covid -19 vaccine it should get through all the stages of trial.
To quote, the WHO spokesman Christian Lindmeier “Any vaccine for this purpose should be, of course, going through all the various trials and tests before being licensed for roll-out,”
Generally the vaccine trials follow a four phase trial system.
Phase One Trials – Introduction of the drug into the human population.
Phase Two Trials – Monitoring more diverse set of healthy volunteers based on the immunogenic results from the phase one trial.
Phase Three Trials – Continue to monitor a larger scale so that the vaccine is proved to be safe and effective in natural disease conditions before being submitted for approval and then general production.
Phase Four Trials – Typically monitor to collect information continuously on vaccine usage, adverse effects, and long-term immunity.
Other vaccines proceeded to the final stage trials are the Pfizer-BioNTech’s formulated mRNA vaccine which is said to have approbative result on pre-clinical trials; then UK-based Oxford University in partnership with pharma maker AstraZeneca and Novavax Inc are bellying up with the covid -19 vaccines.
This Positive news is now gladdening the people a bit by alleviating the fear of the disease.